Hzymes Biotechnology
Shanghai, China· Est.
Chinese synthetic biology company developing engineered enzyme therapeutics and biocatalysts for oncology and metabolic diseases.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
Chinese synthetic biology company developing engineered enzyme therapeutics and biocatalysts for oncology and metabolic diseases.
OncologyMetabolic Disorders
Technology Platform
Synthetic biology and enzyme engineering platform utilizing computational design and directed evolution to create therapeutic enzymes with enhanced properties.
Opportunities
Growing demand for enzyme-based therapeutics in metabolic diseases and oncology, plus potential dual revenue from industrial biocatalyst applications.
Risk Factors
Early-stage platform with unproven clinical translation, intense competition in synthetic biology, and dependence on continued funding in volatile biotech markets.
Competitive Landscape
Competes with synthetic biology platforms like Ginkgo Bioworks and Codexis globally, and Chinese peers like Bota Biosciences, with differentiation through therapeutic enzyme focus.